OFEV is indicated in adults for the treatment of Idiopathic Pulmonary Fibrosis (IPF).
OFEV is also indicated for the treatment of other chronic fibrosing Interstitial Lung Diseases (ILDs) with a progressive phenotype.
OFEV is indicated for the treatment of Systemic Sclerosis associated Interstitial Lung Disease (SSc-ILD).
Other Services
Country
Account